Functional characterization of patient fibroblasts, transdifferentiated myoblasts, and a KO re-expression cell model reveals mtDNA-mediated inflammation likely explains the patient myopathy, thus expanding our understanding of the mechanisms by which MFN2 dysfunction contributes to pathology. The gene discussed is MFN2; the disease is myopathy.